Domino-like effect of C112R mutation on ApoE4 aggregation and its reduction by Alzheimer's Disease drug candidate.

3-sulfopropanoic acid Aggregation Alzheimer’s disease Apolipoprotein E Cerebral organoids HDX-MS Lipidomics Molecular dynamics Neurodegeneration Protein crystallography Proteomics Tramiprosate

Journal

Molecular neurodegeneration
ISSN: 1750-1326
Titre abrégé: Mol Neurodegener
Pays: England
ID NLM: 101266600

Informations de publication

Date de publication:
06 06 2023
Historique:
received: 06 11 2022
accepted: 19 04 2023
medline: 8 6 2023
pubmed: 7 6 2023
entrez: 6 6 2023
Statut: epublish

Résumé

Apolipoprotein E (ApoE) ε4 genotype is the most prevalent risk factor for late-onset Alzheimer's Disease (AD). Although ApoE4 differs from its non-pathological ApoE3 isoform only by the C112R mutation, the molecular mechanism of its proteinopathy is unknown. Here, we reveal the molecular mechanism of ApoE4 aggregation using a combination of experimental and computational techniques, including X-ray crystallography, site-directed mutagenesis, hydrogen-deuterium mass spectrometry (HDX-MS), static light scattering and molecular dynamics simulations. Treatment of ApoE ε3/ε3 and ε4/ε4 cerebral organoids with tramiprosate was used to compare the effect of tramiprosate on ApoE4 aggregation at the cellular level. We found that C112R substitution in ApoE4 induces long-distance (> 15 Å) conformational changes leading to the formation of a V-shaped dimeric unit that is geometrically different and more aggregation-prone than the ApoE3 structure. AD drug candidate tramiprosate and its metabolite 3-sulfopropanoic acid induce ApoE3-like conformational behavior in ApoE4 and reduce its aggregation propensity. Analysis of ApoE ε4/ε4 cerebral organoids treated with tramiprosate revealed its effect on cholesteryl esters, the storage products of excess cholesterol. Our results connect the ApoE4 structure with its aggregation propensity, providing a new druggable target for neurodegeneration and ageing.

Sections du résumé

BACKGROUND
Apolipoprotein E (ApoE) ε4 genotype is the most prevalent risk factor for late-onset Alzheimer's Disease (AD). Although ApoE4 differs from its non-pathological ApoE3 isoform only by the C112R mutation, the molecular mechanism of its proteinopathy is unknown.
METHODS
Here, we reveal the molecular mechanism of ApoE4 aggregation using a combination of experimental and computational techniques, including X-ray crystallography, site-directed mutagenesis, hydrogen-deuterium mass spectrometry (HDX-MS), static light scattering and molecular dynamics simulations. Treatment of ApoE ε3/ε3 and ε4/ε4 cerebral organoids with tramiprosate was used to compare the effect of tramiprosate on ApoE4 aggregation at the cellular level.
RESULTS
We found that C112R substitution in ApoE4 induces long-distance (> 15 Å) conformational changes leading to the formation of a V-shaped dimeric unit that is geometrically different and more aggregation-prone than the ApoE3 structure. AD drug candidate tramiprosate and its metabolite 3-sulfopropanoic acid induce ApoE3-like conformational behavior in ApoE4 and reduce its aggregation propensity. Analysis of ApoE ε4/ε4 cerebral organoids treated with tramiprosate revealed its effect on cholesteryl esters, the storage products of excess cholesterol.
CONCLUSIONS
Our results connect the ApoE4 structure with its aggregation propensity, providing a new druggable target for neurodegeneration and ageing.

Identifiants

pubmed: 37280636
doi: 10.1186/s13024-023-00620-9
pii: 10.1186/s13024-023-00620-9
pmc: PMC10245438
doi:

Substances chimiques

Apolipoprotein E4 0
Apolipoprotein E3 0
tramiprosate 5K8EAX0G53
Apolipoproteins E 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

38

Informations de copyright

© 2023. The Author(s).

Références

J Biomed Sci. 2020 Jan 6;27(1):18
pubmed: 31906949
Protein Eng. 1994 Mar;7(3):385-91
pubmed: 8177887
Biophys J. 2000 Mar;78(3):1606-19
pubmed: 10692345
Methods. 2011 Sep;55(1):94-106
pubmed: 21821126
J Comput Chem. 1999 Jun;20(8):786-798
pubmed: 35619462
Neuron. 2018 Jun 27;98(6):1141-1154.e7
pubmed: 29861287
Diabetol Metab Syndr. 2013 May 14;5(1):24
pubmed: 23672807
J Neurosci. 2012 Sep 19;32(38):13125-36
pubmed: 22993429
Anal Chem. 2023 Feb 14;95(6):3160-3167
pubmed: 36724094
J Med Chem. 2019 Apr 25;62(8):4120-4130
pubmed: 30933499
Nat Commun. 2022 Aug 11;13(1):4726
pubmed: 35953482
Proc Natl Acad Sci U S A. 2013 May 7;110(19):E1807-16
pubmed: 23620513
Biophys J. 2017 Dec 19;113(12):2682-2694
pubmed: 29262361
Stem Cell Res. 2019 Oct;40:101563
pubmed: 31494448
J Chem Theory Comput. 2015 Apr 14;11(4):1864-74
pubmed: 26574392
Transl Psychiatry. 2019 Apr 26;9(1):144
pubmed: 31028243
Mol Neurobiol. 2019 Apr;56(4):2450-2465
pubmed: 30032423
Nat Neurosci. 2022 Aug;25(8):1020-1033
pubmed: 35915180
J Exp Med. 2012 Nov 19;209(12):2149-56
pubmed: 23129750
Biochemistry. 2011 Nov 1;50(43):9273-82
pubmed: 21899263
Transl Psychiatry. 2015 Jan 13;5:e494
pubmed: 25585166
J Neurosci. 2019 Sep 11;39(37):7408-7427
pubmed: 31331998
FEBS Lett. 2019 Jun;593(11):1144-1153
pubmed: 31058310
Anal Chem. 2018 Jun 19;90(12):7608-7616
pubmed: 29807422
J Mol Biol. 2019 May 31;431(12):2248-2265
pubmed: 31051176
J Chem Theory Comput. 2009 Sep 8;5(9):2371-7
pubmed: 26616618
EMBO Mol Med. 2012 Aug;4(8):730-42
pubmed: 22628224
Protein Sci. 2007 Jul;16(7):1389-97
pubmed: 17586772
Cell Stem Cell. 2019 Mar 7;24(3):363-375.e9
pubmed: 30686764
Proc Natl Acad Sci U S A. 2011 Sep 6;108(36):14813-8
pubmed: 21873229
Int J Mol Sci. 2020 Sep 01;21(17):
pubmed: 32882843
Nat Rev Neurol. 2019 Sep;15(9):501-518
pubmed: 31367008
Science. 1993 Aug 13;261(5123):921-3
pubmed: 8346443
J Lipid Res. 2009 Apr;50 Suppl:S183-8
pubmed: 19106071
J Biol Chem. 1981 Sep 10;256(17):9077-83
pubmed: 7263700
Front Aging Neurosci. 2018 Nov 02;10:285
pubmed: 30455639
Protein Sci. 2015 Jan;24(1):138-44
pubmed: 25377861
Neurobiol Aging. 2007 Apr;28(4):537-47
pubmed: 16675063
Proc Natl Acad Sci U S A. 2017 Jun 13;114(24):6292-6297
pubmed: 28559318
Biochemistry. 2011 Sep 27;50(38):8117-26
pubmed: 21848287
Mol Oncol. 2023 Apr;17(4):647-663
pubmed: 36744875
Expert Opin Drug Discov. 2015 May;10(5):449-61
pubmed: 25835573
Clin Pharmacokinet. 2018 Mar;57(3):315-333
pubmed: 29063518
J Biol Chem. 1998 Mar 6;273(10):5645-54
pubmed: 9488694
J Chem Theory Comput. 2013 Jul 9;9(7):3084-95
pubmed: 26583988
Biochemistry. 2007 Sep 18;46(37):10722-32
pubmed: 17715945
Int J Mol Sci. 2021 Jan 27;22(3):
pubmed: 33513969
J Biol Chem. 1996 Aug 9;271(32):19053-7
pubmed: 8702576
Cell. 2012 Mar 16;148(6):1204-22
pubmed: 22424230
Neurosciences (Riyadh). 2012 Oct;17(4):321-6
pubmed: 23022896
Proc Natl Acad Sci U S A. 2017 Jan 31;114(5):968-973
pubmed: 28096372
Proteins. 2008 Nov 15;73(3):765-83
pubmed: 18498103
J Chem Theory Comput. 2012 Sep 11;8(9):3314-21
pubmed: 26605738
Alzheimers Dement. 2023 Feb;19(2):658-670
pubmed: 35652476
Biochemistry. 2010 Nov 9;49(44):9533-41
pubmed: 20923231
J Mol Biol. 2006 Sep 1;361(5):932-44
pubmed: 16890957
Acta Crystallogr D Biol Crystallogr. 2010 Apr;66(Pt 4):486-501
pubmed: 20383002
J Chem Theory Comput. 2009 Jun 9;5(6):1632-9
pubmed: 26609855
J Prev Alzheimers Dis. 2016;3(4):219-228
pubmed: 29199323
Nat Aging. 2022 Apr;2(4):282-284
pubmed: 37117742
Alzheimers Dement. 2022 Apr;18(4):700-789
pubmed: 35289055
Nucleic Acids Res. 2019 Jan 8;47(D1):D442-D450
pubmed: 30395289
J Biol Chem. 2012 Feb 17;287(8):5253-66
pubmed: 22158868
Nat Med. 2018 May;24(5):647-657
pubmed: 29632371
J Biol Chem. 1994 Sep 2;269(35):22358-65
pubmed: 8071364
Transl Psychiatry. 2021 Mar 2;11(1):153
pubmed: 33654056
Annu Rev Neurosci. 1996;19:53-77
pubmed: 8833436
Alzheimers Dement (N Y). 2020 Dec 04;6(1):e12117
pubmed: 33304988
J Prev Alzheimers Dis. 2017;4(3):149-156
pubmed: 29182706
J Biol Chem. 2005 Dec 30;280(52):43236-42
pubmed: 16207708
Proc Natl Acad Sci U S A. 1994 Mar 1;91(5):1834-8
pubmed: 8127890
Biophys J. 2005 Jan;88(1):455-66
pubmed: 15475580
J Comput Chem. 2011 Aug;32(11):2359-68
pubmed: 21541964
Acta Crystallogr D Biol Crystallogr. 2010 Feb;66(Pt 2):125-32
pubmed: 20124692
Biopolymers. 1983 Dec;22(12):2577-637
pubmed: 6667333
Neuron. 2022 Apr 20;110(8):1304-1317
pubmed: 35298921
Nucleic Acids Res. 2018 Jul 2;46(W1):W296-W303
pubmed: 29788355
Biochemistry. 2001 Mar 6;40(9):2826-34
pubmed: 11258893
J Chem Theory Comput. 2016 Apr 12;12(4):1845-52
pubmed: 26949976
Acta Crystallogr D Biol Crystallogr. 2013 Jul;69(Pt 7):1204-14
pubmed: 23793146
J Cheminform. 2012 Aug 13;4(1):17
pubmed: 22889332
Nucleic Acids Res. 2013 Jan;41(Database issue):D475-82
pubmed: 23193259
Nature. 2022 Nov;611(7937):769-779
pubmed: 36385529
J Biol Chem. 2005 Dec 30;280(52):43224-35
pubmed: 16207713
BMC Med. 2019 Mar 20;17(1):64
pubmed: 30890171
Alzheimers Dement (N Y). 2022 May 04;8(1):e12295
pubmed: 35516416
J Chem Phys. 2011 Feb 14;134(6):065101
pubmed: 21322734
Proc Natl Acad Sci U S A. 2000 Mar 14;97(6):2892-7
pubmed: 10694577
Biochim Biophys Acta. 2002 Sep 5;1584(1):9-19
pubmed: 12213488
Am J Pathol. 2022 Mar;192(3):564-578
pubmed: 34954207
J Clin Invest. 2018 May 1;128(5):2144-2155
pubmed: 29600961
J Neurosci. 2019 Nov 27;39(48):9611-9622
pubmed: 31641056
CNS Drugs. 2018 Sep;32(9):849-861
pubmed: 30076539
Neuron. 2017 Dec 6;96(5):1013-1023.e4
pubmed: 29216448
Brain Res. 1991 Feb 8;541(1):163-6
pubmed: 2029618
Cell Chem Biol. 2019 Jan 17;26(1):71-84.e4
pubmed: 30415965
Protein Sci. 2000 May;9(5):886-97
pubmed: 10850798
Biotechniques. 1990 Apr;8(4):404-7
pubmed: 2340178
CNS Drugs. 2017 Jun;31(6):495-509
pubmed: 28435985
Alzheimers Dement (N Y). 2021 May 25;7(1):e12185
pubmed: 34095442
J Appl Crystallogr. 2007 Aug 1;40(Pt 4):658-674
pubmed: 19461840
Cell Rep. 2022 Mar 1;38(9):110435
pubmed: 35235798
Alzheimers Dement. 2021 Apr;17(4):696-701
pubmed: 33135381
J Biol Chem. 2000 Nov 24;275(47):36758-65
pubmed: 10970893
Nat Methods. 2017 Jan;14(1):71-73
pubmed: 27819658
Biochemistry. 2006 Jan 17;45(2):381-90
pubmed: 16401069
Biochemistry. 2000 Sep 26;39(38):11657-66
pubmed: 10995233
J Biol Chem. 1998 Feb 13;273(7):4206-12
pubmed: 9461617
Neuropsychiatr Dis Treat. 2016 Jun 30;12:1589-98
pubmed: 27418826
Methods Enzymol. 2015;562:109-33
pubmed: 26412649

Auteurs

Michal Nemergut (M)

Loschmidt Laboratories, Department of Experimental Biology, Faculty of Science, Masaryk University, Kamenice 5, Brno, 625 00, Czech Republic.
RECETOX, Faculty of Science, Masaryk University, Kamenice 5, Brno, 625 00, Czech Republic.
International Clinical Research Center, St. Anne's University Hospital Brno, Pekarska 53, Brno, 656 91, Czech Republic.
Center for Interdisciplinary Biosciences, Technology and Innovation Park, P. J. Safarik University in Kosice, Trieda SNP 1, Kosice, 04011, Slovakia.

Sérgio M Marques (SM)

Loschmidt Laboratories, Department of Experimental Biology, Faculty of Science, Masaryk University, Kamenice 5, Brno, 625 00, Czech Republic.
RECETOX, Faculty of Science, Masaryk University, Kamenice 5, Brno, 625 00, Czech Republic.
International Clinical Research Center, St. Anne's University Hospital Brno, Pekarska 53, Brno, 656 91, Czech Republic.

Lukas Uhrik (L)

Research Centre for Applied Molecular Oncology, Masaryk Memorial Cancer Institute, Zluty kopec 7, Brno, 656 53, Czech Republic.

Tereza Vanova (T)

International Clinical Research Center, St. Anne's University Hospital Brno, Pekarska 53, Brno, 656 91, Czech Republic.
Department of Histology and Embryology, Faculty of Medicine, Kamenice 5, Brno, 625 00, Czech Republic.

Marketa Nezvedova (M)

RECETOX, Faculty of Science, Masaryk University, Kamenice 5, Brno, 625 00, Czech Republic.

Darshak Chandulal Gadara (DC)

RECETOX, Faculty of Science, Masaryk University, Kamenice 5, Brno, 625 00, Czech Republic.

Durga Jha (D)

RECETOX, Faculty of Science, Masaryk University, Kamenice 5, Brno, 625 00, Czech Republic.

Jan Tulis (J)

Loschmidt Laboratories, Department of Experimental Biology, Faculty of Science, Masaryk University, Kamenice 5, Brno, 625 00, Czech Republic.
RECETOX, Faculty of Science, Masaryk University, Kamenice 5, Brno, 625 00, Czech Republic.

Veronika Novakova (V)

Loschmidt Laboratories, Department of Experimental Biology, Faculty of Science, Masaryk University, Kamenice 5, Brno, 625 00, Czech Republic.
RECETOX, Faculty of Science, Masaryk University, Kamenice 5, Brno, 625 00, Czech Republic.
International Clinical Research Center, St. Anne's University Hospital Brno, Pekarska 53, Brno, 656 91, Czech Republic.

Joan Planas-Iglesias (J)

Loschmidt Laboratories, Department of Experimental Biology, Faculty of Science, Masaryk University, Kamenice 5, Brno, 625 00, Czech Republic.
RECETOX, Faculty of Science, Masaryk University, Kamenice 5, Brno, 625 00, Czech Republic.
International Clinical Research Center, St. Anne's University Hospital Brno, Pekarska 53, Brno, 656 91, Czech Republic.

Antonin Kunka (A)

Loschmidt Laboratories, Department of Experimental Biology, Faculty of Science, Masaryk University, Kamenice 5, Brno, 625 00, Czech Republic.
RECETOX, Faculty of Science, Masaryk University, Kamenice 5, Brno, 625 00, Czech Republic.
International Clinical Research Center, St. Anne's University Hospital Brno, Pekarska 53, Brno, 656 91, Czech Republic.

Anthony Legrand (A)

Loschmidt Laboratories, Department of Experimental Biology, Faculty of Science, Masaryk University, Kamenice 5, Brno, 625 00, Czech Republic.
RECETOX, Faculty of Science, Masaryk University, Kamenice 5, Brno, 625 00, Czech Republic.
International Clinical Research Center, St. Anne's University Hospital Brno, Pekarska 53, Brno, 656 91, Czech Republic.

Hana Hribkova (H)

Department of Histology and Embryology, Faculty of Medicine, Kamenice 5, Brno, 625 00, Czech Republic.

Veronika Pospisilova (V)

International Clinical Research Center, St. Anne's University Hospital Brno, Pekarska 53, Brno, 656 91, Czech Republic.
Department of Histology and Embryology, Faculty of Medicine, Kamenice 5, Brno, 625 00, Czech Republic.

Jiri Sedmik (J)

International Clinical Research Center, St. Anne's University Hospital Brno, Pekarska 53, Brno, 656 91, Czech Republic.
Department of Histology and Embryology, Faculty of Medicine, Kamenice 5, Brno, 625 00, Czech Republic.

Jan Raska (J)

International Clinical Research Center, St. Anne's University Hospital Brno, Pekarska 53, Brno, 656 91, Czech Republic.
Department of Histology and Embryology, Faculty of Medicine, Kamenice 5, Brno, 625 00, Czech Republic.

Zbynek Prokop (Z)

Loschmidt Laboratories, Department of Experimental Biology, Faculty of Science, Masaryk University, Kamenice 5, Brno, 625 00, Czech Republic.
RECETOX, Faculty of Science, Masaryk University, Kamenice 5, Brno, 625 00, Czech Republic.
International Clinical Research Center, St. Anne's University Hospital Brno, Pekarska 53, Brno, 656 91, Czech Republic.

Jiri Damborsky (J)

Loschmidt Laboratories, Department of Experimental Biology, Faculty of Science, Masaryk University, Kamenice 5, Brno, 625 00, Czech Republic.
RECETOX, Faculty of Science, Masaryk University, Kamenice 5, Brno, 625 00, Czech Republic.
International Clinical Research Center, St. Anne's University Hospital Brno, Pekarska 53, Brno, 656 91, Czech Republic.

Dasa Bohaciakova (D)

International Clinical Research Center, St. Anne's University Hospital Brno, Pekarska 53, Brno, 656 91, Czech Republic. bohaciakova@med.muni.cz.
Department of Histology and Embryology, Faculty of Medicine, Kamenice 5, Brno, 625 00, Czech Republic. bohaciakova@med.muni.cz.

Zdenek Spacil (Z)

RECETOX, Faculty of Science, Masaryk University, Kamenice 5, Brno, 625 00, Czech Republic. spacil@recetox.muni.cz.

Lenka Hernychova (L)

Research Centre for Applied Molecular Oncology, Masaryk Memorial Cancer Institute, Zluty kopec 7, Brno, 656 53, Czech Republic. lenka.hernychova@mou.cz.

David Bednar (D)

Loschmidt Laboratories, Department of Experimental Biology, Faculty of Science, Masaryk University, Kamenice 5, Brno, 625 00, Czech Republic. 222755@muni.cz.
RECETOX, Faculty of Science, Masaryk University, Kamenice 5, Brno, 625 00, Czech Republic. 222755@muni.cz.
International Clinical Research Center, St. Anne's University Hospital Brno, Pekarska 53, Brno, 656 91, Czech Republic. 222755@muni.cz.

Martin Marek (M)

Loschmidt Laboratories, Department of Experimental Biology, Faculty of Science, Masaryk University, Kamenice 5, Brno, 625 00, Czech Republic. martin.marek@recetox.muni.cz.
RECETOX, Faculty of Science, Masaryk University, Kamenice 5, Brno, 625 00, Czech Republic. martin.marek@recetox.muni.cz.
International Clinical Research Center, St. Anne's University Hospital Brno, Pekarska 53, Brno, 656 91, Czech Republic. martin.marek@recetox.muni.cz.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH